Ingredient

Valerian

Products with Valerian on sale in the United Kingdom.

Find products
Share

Email article

Valerian is the root and rhizome of Valeriana officinalis. The plant is native to Europe and Asia and also grows in North America. Supplements hold dried root, powders or extracts; the dried root is also made into teas and tinctures. Some extracts are standardized to valerenic acids or other compounds of the root.

Terms and sources
rhizome
An underground stem. NIH also names the stolons, or horizontal stems. NIH Office of Dietary Supplements, Valerian: Fact Sheet for Health Professionals.
also grows in North America
NCCIH, Valerian: Usefulness and Safety.
teas and tinctures
NIH Office of Dietary Supplements, Valerian: Fact Sheet for Health Professionals.
other compounds
NIH names volatile oils including valerenic acids, the less volatile sesquiterpenes, and valepotriates. NIH Office of Dietary Supplements, Valerian: Fact Sheet for Health Professionals.

Valerian in the body

Valerian is not a nutrient, and the body has no daily requirement for it. Trials in adults without a diagnosis measure sleep ratings, reaction time and valerenic acid in blood.

NIH notes there is no scientific agreement on which compounds of valerian are active. NIH adds that its activity may come from several compounds together, not one. In one study, valerenic acid in blood peaked 1 to 2 hours after a 600 mg dose. Its half-life in blood was about 1.1 hours.

Terms and sources
no scientific agreement
NIH Office of Dietary Supplements, Valerian: Fact Sheet for Health Professionals.
several compounds
NIH Office of Dietary Supplements, Valerian: Fact Sheet for Health Professionals.
In one study
In 5 of 6 healthy adults. Anderson et al., Phytotherapy Research, 2005, below.
half-life
The time for the blood level to fall by half: 1.1 ± 0.6 hours. Anderson et al., 2005.

Safety: what NIH and NCCIH say

NIH, on harms: "Few adverse events attributable to valerian have been reported for clinical study participants." NIH adds: "Headaches, dizziness, pruritus, and gastrointestinal disturbances are the most common effects reported in clinical trials but similar effects were also reported for the placebo." NIH adds: "In one study an increase in sleepiness was noted the morning after 900 mg of valerian was taken." NIH adds: "Investigators from another study concluded that 600 mg of valerian (LI 156) did not have a clinically significant effect on reaction time, alertness, and concentration the morning after ingestion." NIH adds: "Several case reports described adverse effects, but in one case where suicide was attempted with a massive overdose it is not possible to clearly attribute the symptoms to valerian."

Terms and sources
on harms
Quoted in full: the NIH sections on harms, on who should not take it, and on interactions. This paragraph and the next four. Reference numbers are left out. NIH Office of Dietary Supplements, Valerian: Fact Sheet for Health Professionals.

NIH adds: "Valepotriates, which are a component of valerian but are not necessarily present in commercial preparations, had cytotoxic activity in vitro but were not carcinogenic in animal studies."

NIH, on who should not take it: "Women who are pregnant or nursing should not take valerian without medical advice because the possible risks to the fetus or infant have not been evaluated." NIH adds: "Children younger than 3 years old should not take valerian because the possible risks to children of this age have not been evaluated." NIH adds: "Individuals taking valerian should be aware of the theoretical possibility of additive sedative effects from alcohol or sedative drugs, such as barbiturates and benzodiazepines."

NIH, on interactions: "Valerian might have additive therapeutic and adverse effects if taken with sedatives, other medications, or certain herbs and dietary supplements with sedative properties. These include the following:" NIH lists: "Benzodiazepines such as Xanax®, Valium®, Ativan®, and Halcion®." NIH lists: "Barbiturates or central nervous system (CNS) depressants such as phenobarbital (Luminal®), morphine, and propofol (Diprivan®)." NIH lists: "Dietary supplements such as St. John’s wort, kava, and melatonin."

NIH adds: "Individuals taking these medications or supplements should discuss the use of valerian with their healthcare providers." NIH adds: "Although valerian has not been reported to influence laboratory tests, this has not been rigorously studied."

NCCIH, on safety: "Research suggests that valerian is generally safe for short-term use by most adults. It has been used with apparent safety in doses of 300 to 600 milligrams daily for up to 6 weeks. The safety of long-term use of valerian is unknown."

Terms and sources
on safety
The NCCIH safety section, quoted in full in this paragraph and the next three. NCCIH, Valerian: Usefulness and Safety.

NCCIH adds: "Side effects of valerian include headache, stomach upset, mental dullness, excitability, uneasiness, and vivid dreams. Some may experience withdrawal symptoms, including anxiety, irritability, heart disturbances, insomnia, and in rare cases, hallucinations, if stopped abruptly after chronic use. In very rare cases, liver injury was reported when taking valerian, most often in combination with other herbals; however, valerian’s long-term effect on liver function is unknown."

NCCIH adds: "Because it is possible (though not proven) that valerian might have a sleep-inducing effect, it should not be taken along with alcohol or sedatives. If you take any type of medicine, talk with your health care provider before using valerian or other herbal products; some herbs and medicines interact in harmful ways."

NCCIH adds: "Little is known about whether it’s safe to use valerian during pregnancy or while breastfeeding."

Where valerian comes from

Valeriana officinalis is a perennial plant; NIH places it in the Valerianaceae family. Italy's 2018 plant list places it in the Caprifoliaceae family. NIH notes that the genus has over 250 species. Valeriana officinalis is the one most often used in the United States and Europe, NIH adds.

Terms and sources
Valerianaceae
NIH Office of Dietary Supplements, Valerian: Fact Sheet for Health Professionals.
Caprifoliaceae
Italian Ministry of Health, list of plants for food supplements, 2018.
over 250 species
NIH Office of Dietary Supplements, Valerian: Fact Sheet for Health Professionals.

NIH notes that the root has a distinctive odor that many find unpleasant. NIH adds that levels of its compounds vary among plants with the time of harvest.

Terms and sources
distinctive odor
NIH Office of Dietary Supplements, Valerian: Fact Sheet for Health Professionals.
time of harvest
NIH Office of Dietary Supplements, Valerian: Fact Sheet for Health Professionals.

Daily amounts and the upper limit

United States

There is no US recommended daily amount for valerian. The National Academies have not set an upper limit for valerian.

In the NIH label database, 2,242 US labels list valerian. 85% of them list other ingredients too.

Terms and sources
2,242 US labels
NIH Dietary Supplement Label Database, including products no longer sold. Labels with an ingredient or form named valerian, Valeriana officinalis or valerenic acid. Another 16 name only another Valeriana species or red valerian. We counted these.
85%
1,900 of 2,242. Labels where every ingredient is valerian or its valerenic acids are counted as valerian only. Calorie and carbohydrate rows are ignored.

Of the 2,242 labels, 981 also list passionflower, 737 list hops and 656 list chamomile.

Terms and sources
981
We counted these. 479 list lemon balm, 474 melatonin and 388 L-theanine.

In 135 extract labels whose only ingredient is valerian, the middle half list 450–1,000 mg per serving. Labels that do not call it an extract list more: the middle half of 123 list 500–1,250 mg. Of these 258 labels, 143 list more than 600 mg per serving.

Terms and sources
135 extract labels
The median is 625 mg. Amounts in mg or g, converted to mg. A serving is not always a full day's amount.
per serving
Left out: 31 labels in mL, 28 with no amount and 25 that list valerian twice. We counted these.
123
Ingredient names without the word extract. The median is 1,000 mg.
143
600 mg a day is the upper end of the range NCCIH describes, in the safety section above. We counted these.

260 labels name valerenic acid. On 22 of 31 labels that give valerian and valerenic acid in mg, it comes to 0.8%.

Terms and sources
22 of 31
By our calculation. 4 come to 0.4% and 2 to 1%.

Of 342 labels whose only ingredient is valerian, 203 carry a precaution to consult a doctor or health professional.

Terms and sources
203 carry a precaution
A precaution statement on the label with the words consult, physician or ask a doctor. 98 mention driving or machinery. We counted these.

Forms of valerian and how they differ

Supplements sell valerian as dried root, root powder, extracts and liquid extracts. The trials below used an aqueous extract, a root extract and one product whose form is not named.

Terms and sources
liquid extracts
NIH notes that dried roots are made into teas or tinctures. Dried root and extracts go into capsules or tablets. NIH Office of Dietary Supplements, Valerian: Fact Sheet for Health Professionals.
one product
Anderson et al., 2005, below: the abstract says only 600 mg of valerian.
Valerian forms in the studies below
FormWhat it isStudies below
Aqueous extractExtract of valerian root made with waterLeathwood 1982 (400 mg on test nights)
Root extractNative valerian root extract coded LI 156; the abstract does not say how it was madeKuhlmann 1999 (600 mg each evening)
Form not statedValerian; the abstract does not name the productAnderson 2005 (600 mg once)

What it is: the trial reports named in the third column.

Published studies of valerian

Most valerian trials studied people with a diagnosis or chose people by their complaints. Those trials are not listed here, nor are studies of valerian mixed with other herbs.

We list trials with up to 600 mg of valerian a day.

Terms and sources
up to 600 mg
NCCIH: "It has been used with apparent safety in doses of 300 to 600 milligrams daily for up to 6 weeks." NCCIH does not say whether this is root or extract. NCCIH, Valerian: Usefulness and Safety.

3 studies in adults without a diagnosis. Against a dummy product, 1 found a difference and 1 found none. 1 measured valerenic acid in blood after one dose.

6 to 128 people each. Not listed: studies in children, in people with a diagnosis or taking medicines, or around surgery or a dental procedure. Nor are studies that chose people by their complaints or by a questionnaire score. Also not listed: more than 600 mg a day, blends with other herbs, other Valeriana species, or other routes. Nor are studies without stated random assignment, or with a branded product whose contents are not stated. Nor are reviews that include such studies. Groups given a medicine are not counted.

Our one-line summary comes first. The original is on PubMed.

Show the 3 studies
  • Among 128 people, rated time to fall asleep was shorter with 400 mg valerian extract than with a dummy product.

    Trial · 128 people · 9 test nights · funding not stated

    Leathwood et al., Pharmacology, Biochemistry and Behavior, 1982

    Terms and sources
    128 people
    People were not chosen by a diagnosis. NIH notes that having a sleep diagnosis was not required, and that 22.9% of participants withdrew. NIH Office of Dietary Supplements.
    rated time to fall asleep
    Scores on a morning questionnaire were significantly lower with valerian. Sleep quality ratings were also significantly higher. Night awakenings, dream recall and next-morning sleepiness were "relatively unaffected", in the abstract's words. NIH reports a significant difference in night awakenings as well. The abstract gives no scores.
    400 mg valerian extract
    An aqueous extract of Valeriana officinalis root, taken on 3 non-consecutive nights.
    a dummy product
    Each person took 9 coded samples on non-consecutive nights, in random order. Three were dummy, three valerian extract and three an over-the-counter product. NIH notes that this product held 60 mg valerian and 30 mg hops. It is a blend and is not counted here. The abstract does not say whether samples were capsules.
    funding not stated
    The abstract names no funder. PubMed and Europe PMC list no affiliations or grants. We read only the abstract.

    Study · Abstract only · about 2 min to read

    Abstract only. Our estimate at about 200 words a minute, from the PubMed abstract.

    Study summary

    128 people each took 9 coded samples on non-consecutive nights, in random order. Three held 400 mg of an aqueous valerian root extract, three a dummy, and three an over-the-counter product. Each morning they rated time to fall asleep, sleep quality, night awakenings, dream recall and sleepiness. Rated time to fall asleep was shorter and sleep quality higher with the extract. The other ratings were relatively unaffected. People were not chosen by a diagnosis. Funding: not stated in the abstract.

  • After 14 evenings of 600 mg valerian root extract or a dummy product, morning reaction time did not differ significantly.

    Trial · 102 randomized in all, including a medicine group in section A; 91 analyzed in section B. The abstract does not give group sizes. · 14 days · industry author

    Kuhlmann et al., Pharmacopsychiatry, 1999

    Terms and sources
    14 evenings
    Section B of the trial, in which 91 volunteers were analyzed. In section A, 99 were analyzed after one evening dose.
    600 mg valerian root extract
    A native valerian root extract coded LI 156, in the abstract's words, taken in the evening. The abstract does not name its maker.
    a dummy product
    The abstract calls it placebo and does not describe its form. In section A, a third group took one dose of a prescription medicine. That group is not counted here.
    did not differ significantly
    The authors report that the two were equivalent on the change in reaction time (p = 0.4481). They write that alertness, coordination and sleep quality results were consistent with this. After one dose, in section A, reaction, concentration and coordination were not impaired, in the abstract's words. The abstract gives no reaction times and no side-effect counts.
    industry author
    The first author is at Lichtwer Pharma AG, Berlin, by PubMed. Europe PMC lists no funder. We read only the abstract, so we could not check the funding section.

    Study · Abstract only · about 2 min to read

    Abstract only. Our estimate at about 200 words a minute, from the PubMed abstract.

    Study summary

    102 volunteers took part in a trial with two sections. In section A, people took one evening dose of 600 mg valerian root extract, a dummy or a prescription medicine. In section B, the extract or a dummy was taken each evening for 14 days; 91 people were analyzed. Reaction time was tested the next morning. The authors report equivalent changes in reaction time with extract and dummy. One dose did not impair reaction, concentration or coordination. The abstract describes no diagnosis. Funding: not stated in the abstract.

  • 6 healthy adults took one 600 mg dose of valerian; blood valerenic acid peaked 1–2 hours later in 5.

    Trial · 6 people · Single dose

    Anderson et al., Phytotherapy Research, 2005

    Terms and sources
    6 healthy adults
    Aged 22 to 61: five men and one woman. Europe PMC lists an NIH grant as the funder. We read only the abstract, so we could not check who made the product.
    600 mg dose of valerian
    Taken at 8 a.m. The abstract does not name the product or say whether it was root or extract.
    valerenic acid
    A compound used as a marker for valerian root and valerian products, in the authors' words.
    peaked 1–2 hours later in 5
    Peak levels were 0.9 to 2.3 ng/mL. Valerenic acid stayed measurable for at least 5 hours. One person peaked at 1 hour and again at 5 hours. Half-life 1.1 ± 0.6 hours.

    Study · Abstract only · about 2 min to read

    Abstract only. Our estimate at about 200 words a minute, from the PubMed abstract.

    Study summary

    6 healthy adults aged 22 to 61 took a single 600 mg dose of valerian at 8 a.m. Blood was sampled for 8 hours and valerenic acid measured. In 5 of the 6, it peaked between 1 and 2 hours, at 0.9 to 2.3 ng/mL. It stayed measurable for at least 5 hours. The half-life was 1.1 hours. There was no comparison group. Funding: Europe PMC lists an NIH grant.

Sources

Information, not a prescription. Do not start, stop or combine supplements or medicines on your own.

Products with Valerian on sale in the United Kingdom

View products with filters

Lowest price per day first. Status shown for the United Kingdom.

No products match this list.

Not sure what to choose, or couldn’t find what you were looking for? Ask our expert

Information, not a prescription. Do not start, stop or combine supplements or medicines on your own. If you have a health condition, are pregnant or breastfeeding, take medicines, or are under 18, talk to a doctor or pharmacist first.